{"id":"https://openalex.org/W4242249916","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.2077","title":"Survival efficacy of adjuvant cytosine-analog CS-682 in a fluorescent orthotopic model of human pancreatic cancer","display_name":"Survival efficacy of adjuvant cytosine-analog CS-682 in a fluorescent orthotopic model of human pancreatic cancer","publication_year":2004,"publication_date":"2004-07-15","ids":{"openalex":"https://openalex.org/W4242249916","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.2077"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2004.22.14_suppl.2077","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.2077","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.2077","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"M. Katz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4210121314","display_name":"AntiCancer (United States)","ror":"https://ror.org/02pp1v282","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121314"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Katz","raw_affiliation_strings":["University of California, San Diego, CA; AntiCancer, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Diego, CA; AntiCancer, Inc., San Diego, CA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4210121314"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009960666","display_name":"Michael Bouvet","orcid":"https://orcid.org/0000-0002-0086-2159","observed_orcids":["https://orcid.org/0000-0002-0086-2159"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4210121314","display_name":"AntiCancer (United States)","ror":"https://ror.org/02pp1v282","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121314"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Bouvet","raw_affiliation_strings":["University of California, San Diego, CA; AntiCancer, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Diego, CA; AntiCancer, Inc., San Diego, CA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4210121314"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044078655","display_name":"Shinako Takimoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4210121314","display_name":"AntiCancer (United States)","ror":"https://ror.org/02pp1v282","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121314"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Takimoto","raw_affiliation_strings":["University of California, San Diego, CA; AntiCancer, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Diego, CA; AntiCancer, Inc., San Diego, CA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4210121314"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081371376","display_name":"Daniel Spivack","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4210121314","display_name":"AntiCancer (United States)","ror":"https://ror.org/02pp1v282","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121314"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Spivack","raw_affiliation_strings":["University of California, San Diego, CA; AntiCancer, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Diego, CA; AntiCancer, Inc., San Diego, CA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4210121314"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108584559","display_name":"A. R. Moossa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4210121314","display_name":"AntiCancer (United States)","ror":"https://ror.org/02pp1v282","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121314"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Moossa","raw_affiliation_strings":["University of California, San Diego, CA; AntiCancer, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Diego, CA; AntiCancer, Inc., San Diego, CA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4210121314"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040819666","display_name":"Robert M. Hoffman","orcid":"https://orcid.org/0000-0002-0049-0041","observed_orcids":["https://orcid.org/0000-0002-0049-0041"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4210121314","display_name":"AntiCancer (United States)","ror":"https://ror.org/02pp1v282","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121314"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. M. Hoffman","raw_affiliation_strings":["University of California, San Diego, CA; AntiCancer, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Diego, CA; AntiCancer, Inc., San Diego, CA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4210121314"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":"14_suppl","first_page":"2077","last_page":"2077"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10760","display_name":"Pancreatitis Pathology and Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cytosine-analogs","display_name":"cytosine analogs","score":0.8690000176429749},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9290000200271606},{"id":"https://openalex.org/keywords/adjuvant-chemotherapy","display_name":"adjuvant chemotherapy","score":0.996999979019165},{"id":"https://openalex.org/keywords/orthotopic-nude-mouse-model","display_name":"orthotopic nude mouse model","score":0.8809999823570251},{"id":"https://openalex.org/keywords/fluorescence-imaging","display_name":"fluorescence imaging","score":0.7149999737739563},{"id":"https://openalex.org/keywords/surgical-resection","display_name":"surgical resection","score":0.8450000286102295},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.6850000023841858},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.6449999809265137},{"id":"https://openalex.org/keywords/oral-chemotherapy","display_name":"oral chemotherapy","score":0.6570000052452087}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8800432682037354},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.6858146786689758},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.601446807384491},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5449097156524658},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5072228908538818},{"id":"https://openalex.org/C2778764654","wikidata":"https://www.wikidata.org/wiki/Q9618","display_name":"Pancreas","level":2,"score":0.4929318428039551},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4641704559326172},{"id":"https://openalex.org/C2780283643","wikidata":"https://www.wikidata.org/wiki/Q2110267","display_name":"Primary tumor","level":4,"score":0.45467549562454224},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.436718225479126},{"id":"https://openalex.org/C2777982462","wikidata":"https://www.wikidata.org/wiki/Q2481887","display_name":"Adjuvant therapy","level":3,"score":0.4325670599937439},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.389394611120224},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.37882348895072937},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.35964083671569824},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.35026097297668457},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.3121643662452698}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2004.22.14_suppl.2077","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.2077","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.2077","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"doi:10.1200/jco.2004.22.90140.2077","doi":"https://doi.org/10.1200/jco.2004.22.90140.2077","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.90140.2077","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2141666493","https://openalex.org/W2007659103","https://openalex.org/W2145124830","https://openalex.org/W2318872594","https://openalex.org/W7145124534","https://openalex.org/W2562518091","https://openalex.org/W2920957991","https://openalex.org/W2104644172","https://openalex.org/W2098287151","https://openalex.org/W3089128352"],"abstract_inverted_index":{"2077":[0],"Background:":[1],"We":[2],"have":[3],"previously":[4],"shown":[5],"that":[6,236],"the":[7,82,99,221],"cytosine":[8],"analog":[9],"CS-682":[10,27,73,150,241],"is":[11,245],"active":[12],"in":[13,28,43,259],"orthotopic":[14,32],"metastatic":[15],"nude":[16,33],"mouse":[17,34],"models":[18],"of":[19,36,72,84,98,105,122,129,175,202,220,240,256],"human":[20,37],"pancreatic":[21,38,223,243],"cancer.":[22],"The":[23,233],"current":[24],"study":[25],"evaluates":[26],"a":[29,126,136],"novel":[30],"adjuvant-treatment":[31],"model":[35],"cancer":[39,244],"with":[40,45,117,125,200,248],"efficacy":[41],"visualized":[42],"real-time":[44],"fluorescence":[46],"imaging.":[47],"Methods:":[48],"Seven":[49],"days":[50,190],"after":[51,217],"implantation,":[52],"mice":[53,120],"were":[54,63],"randomized":[55],"into":[56],"eight":[57],"groups,":[58],"depending":[59],"on":[60,91],"whether":[61],"they":[62],"to":[64,160,229,266],"be":[65],"treated":[66],"by":[67,211],"tumor":[68,100,113,224],"resection,":[69],"five":[70],"weeks":[71],"chemotherapy":[74],"at":[75,152,173],"40\u201360":[76],"mg/kg":[77,177,180],"qd":[78],"or":[79],"both.":[80],"Throughout":[81],"course":[83],"treatment,":[85],"non-invasive":[86],"optical":[87],"whole-body":[88],"imaging":[89],"based":[90],"brilliant":[92],"red":[93],"fluorescent":[94],"protein":[95],"(RFP)":[96],"expression":[97],"permitted":[101],"visualization":[102],"and":[103,108,166,178,188],"quantification":[104],"primary,":[106],"metastatic,":[107],"recurrent":[109],"disease.":[110],"Results:":[111],"Total":[112],"burden":[114],"negatively":[115],"correlated":[116],"survival.":[118],"Untreated":[119],"died":[121],"disseminated":[123],"disease":[124,258],"median":[127],"survival":[128,140,143,158,182,196],"26":[130],"days.":[131],"Surgical":[132],"resection":[133,219],"alone":[134,172],"conferred":[135],"small":[137],"but":[138],"significant":[139,263],"advantage":[141],"(median":[142,181,197],"28":[144],"days,":[145,184,199],"p":[146,185,191],"=":[147,186,192,226],"0.03).":[148],"Primary":[149],"treatment":[151],"all":[153],"doses":[154,174],"also":[155],"significantly":[156],"prolonged":[157],"compared":[159,228],"untreated":[161],"animals":[162,203],"(p":[163,225],"<":[164],"0.05),":[165],"was":[167,209],"more":[168],"effective":[169,247],"than":[170,206],"surgery":[171,230],"50":[176,214],"60":[179,207],"34":[183],"0.045":[187],"38.5":[189],"0.03,":[193],"respectively).":[194],"Maximal":[195],"48":[198],"30%":[201],"surviving":[204],"longer":[205],"days)":[208],"achieved":[210],"adjuvant":[212,237],"CS-682,":[213],"mg/kg,":[215],"given":[216],"surgical":[218],"primary":[222],"0.004":[227],"alone).":[231],"Conclusions:":[232],"results":[234],"demonstrate":[235],"oral":[238],"administration":[239],"for":[242,254],"highly":[246],"acceptable":[249],"toxicity":[250],"suggesting":[251],"its":[252],"potential":[253],"cure":[255],"this":[257],"appropriate":[260],"combinations.":[261],"No":[262],"financial":[264],"relationships":[265],"disclose.":[267]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-05-12T00:00:00"}